Are you saying that Simufilam would have applications on "the entire family of CNS diseases, including the RARE 200+ listed?
Am I reading you right?
Would you happen to have ANY IDEA what they could collectively represent in terms of population?
Also I see Biogen's "treatment" is at $56,000.00/yr Any idea of the $25-$30k figure is reasonable?
So far the best I could find is BABY BOOMERS pushing the total number of those diagnosed with Alzheimer's UP from 44M to about 50M globally over the next few years & is said to continue for a decade or more.
Market Size: ~50M Drug cost: ~$30k/yr Total Market: ~$1.5T/yr
That does NOT include the 200 or so RARE CNS & other CNS applications if I read your post correctly.
Market Data 
Markets 
AI
